# Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD)

> **NCT06927024** · NA · RECRUITING · sponsor: **NYU Langone Health** · enrollment: 30 (estimated)

## Conditions studied

- Chronic Kidney Diseases

## Interventions

- **DEVICE:** Active taVNS
- **DEVICE:** Sham taVNS

## Key facts

- **NCT ID:** NCT06927024
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-15
- **Primary completion:** 2029-01-31
- **Final completion:** 2029-01-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-12-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06927024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06927024, "Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06927024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*